SCHEMBL19685693

SCHEMBL19685693

Cc1cc(=O)c2cc(-n3c4ccccc4c4cc(-n5c6ccccc6c6ccccc65)ccc43)ccc2o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.49
CYP1A2 P05177 3/20 0.41
CYP1A1 P04798 2/20 0.41
CYP1B1 Q16678 2/20 0.41
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 4/20 0.39
TP53 P04637 4/20 0.39
MAPT P10636 4/20 0.39
HSD17B10 Q99714 3/20 0.39
CYP3A4 P08684 3/20 0.39
HPGD P15428 2/20 0.39
MAOB P27338 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ATM Q13315 1/20 0.38
TNKS O95271 1/20 0.37
PARP1 P09874 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
PARP2 Q9UGN5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685800 0.91 ACHE (0.39) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL19685694 0.87 PLA2G2A (0.50) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL19685697 0.84 ACHE (0.45) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL25625682 0.81 CHRNA7 (0.48) KDM4EALDH1A1MAPTHSD17B10CYP3A4
SCHEMBL16582807 0.81 KDM4E (0.48) CYP1A2KDM4EALDH1A1MAPTHSD17B10
SCHEMBL14679586 0.81 KDM4E (0.48) CYP1A2KDM4EALDH1A1MAPTHSD17B10
SCHEMBL18266037 0.81 KDM4E (0.48) CYP1A2KDM4EALDH1A1MAPTHSD17B10
SCHEMBL24359616 0.79 MAOA (0.53) KDM4EALDH1A1MAPTHSD17B10CYP3A4
SCHEMBL17850761 0.79 KDM4E (0.41) ACHEKDM4EALDH1A1TP53MAPT
SCHEMBL17993385 0.79 KDM4E (0.41) ACHEKDM4EALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS ACHE 3408/4885CYP1A2 902/4885CYP1A1 102/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS ACHE 3408/4885CYP1A2 902/4885CYP1A1 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.